These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10755038)

  • 21. Migraine associated with menstruation.
    MacGregor A
    Funct Neurol; 2000; 15 Suppl 3():143-53. PubMed ID: 11200785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex hormones and headache.
    Silberstein SD
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S30-41. PubMed ID: 11139745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicentre randomised trial to compare uterine safety of raloxifene with a continuous combined hormone replacement therapy containing oestradiol and norethisterone acetate.
    Neven P; Lunde T; Benedetti-Panici P; Tiitinen A; Marinescu B; de Villiers T; Hillard T; Cano A; Peer E; Quail D; Nickelsen T;
    BJOG; 2003 Feb; 110(2):157-67. PubMed ID: 12618160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy and irregular bleeding.
    Hickey M; Higham JM; Fraser IS
    Climacteric; 2001 Jun; 4(2):95-101. PubMed ID: 11428183
    [No Abstract]   [Full Text] [Related]  

  • 25. Hormonal therapy and depression: are we overlooking an important therapeutic alternative?
    Ancelin ML; Scali J; Ritchie K
    J Psychosom Res; 2007 Apr; 62(4):473-85. PubMed ID: 17383500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bleeding with menopausal hormone therapy: physiological or pathological?
    Hickey M
    Menopause Int; 2007 Dec; 13(4):188-90. PubMed ID: 18088532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
    Henzl MR; Loomba PK
    J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
    Lethaby AE; Vollenhoven BJ
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The use of hormonal contraception in perimenopause is still a hazard?].
    Buttarelli M; Ghezzi F; Cromi A; Raio L; Franchi M
    Minerva Ginecol; 2001 Dec; 53(6):421-9. PubMed ID: 11723427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR;
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Migraine from a female perspective].
    Dahlöf C; Ehrenborg A
    Lakartidningen; 2007 Jun 4-11; 104(23):1812-4. PubMed ID: 17655028
    [No Abstract]   [Full Text] [Related]  

  • 32. Menstrual cycle bleeding patterns in cigarette smokers.
    Grossman MP; Nakajima ST
    Contraception; 2006 Jun; 73(6):562-5. PubMed ID: 16730484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The assessment of bleeding patterns in postmenopausal women during continuous combined hormone replacement therapy: a review of methodology and recommendations for reporting of the data.
    Archer DF; Pickar JH
    Climacteric; 2002 Mar; 5(1):45-59. PubMed ID: 11974559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of a contraceptive without estrogens (Exlutona) (author's transl)].
    Iliev G; Iliev D
    Med Klin; 1974 Sep; 69(38):1537-40. PubMed ID: 4437440
    [No Abstract]   [Full Text] [Related]  

  • 35. The importance of patient education in improving compliance.
    Sturdee DW
    Climacteric; 2000 Dec; 3 Suppl 2():9-13. PubMed ID: 11379385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen therapy: from women's choice to women's preference.
    Lachowsky M
    Climacteric; 2002 Jun; 5 Suppl 2():46-9. PubMed ID: 12482111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing young women's decision making regarding hormonal contraceptives: a qualitative study.
    Cheung E; Free C
    Contraception; 2005 Jun; 71(6):426-31. PubMed ID: 15914131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genitourinary symptoms in the menopausal transition.
    Van Voorhis BJ
    Am J Med; 2005 Dec; 118 Suppl 12B():47-53. PubMed ID: 16414326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives.
    Archer DF
    Contraception; 2006 Nov; 74(5):359-66. PubMed ID: 17046376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum levels of nitric oxide metabolites among users of levonorgestrel-releasing implants [corrected] a possible role in progestin-induced bleeding.
    Shaamash AH; Zakhari MM
    Hum Reprod; 2005 Jan; 20(1):302-6. PubMed ID: 15471931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.